Normal human cells whether embryonic, neonatal, or adult are resistant to experimentally induced tumorigenesis in contrast to rodent or chicken cells. We showed previously that neither transformation with simian virus 40 DNA nor transfection with human mutant HRAS DNA immortalized FS-2 cells (diploid, neonatal human fibroblasts). Fur- 
The resistance of normal human cells grown in culture to experimentally induced tumorigenesis is very well documented (e.g., refs. [1] [2] [3] [4] [5] . Spontaneous transformation of explanted normal human cells has not been reported. Indeed, such cells maintain normal growth patterns until they senesce, after a variable number of population doublings that are influenced by nutrition and other conditions of cell culture. After senescence no transformed survivors remain from which cell lines can be established, in contrast to rodent cells. Extensive efforts to induce immortalization and tumor forming ability by treatment with chemical carcinogens or radiation have consistently failed with explanted normal human fibroblasts of embryonic, neonatal, or adult origin. Rare instances have been reported in one or a few exceptional clones following exposure of large fibroblast populations to chemicals (6, 7), x-rays (8) , simian virus 40 (SV40) (9) , or adenovirus 5 DNA (10), but none of these experiments have yielded consistent results to provide a basis for analysis of underlying mechanisms. Epithelial cells in culture may be slightly more susceptible to immortalization than fibroblasts (e.g., refs. 11 and 12).
The transforming genes of DNA tumor viruses such as SV40 can induce partial transformation of human fibroblasts, but not tumorigenesis (1, 13) . This behavior contrasts sharply with that ofrodent cells, which routinely undergo crisis in cell culture and produce transformed survivors, as well as undergoing cell transformation after treatment with carcinogens, radiation, or any one of numerous viruses or viral transforming genes (14, 15) .
With the availability of cloned retroviral oncogenes and their cellular homologs, it became possible to examine directly whether DNA sequences that are oncogenic in rodent cells might also be oncogenic in human cell cultures. Experiments addressing this question have been carried out in this laboratory with a population of neonatal (foreskinderived) human diploid fibroblasts, designated FS-2 (2).
Foci of cells containing SV40 DNA and expressing tumor (T)-antigen were recovered after transfection with SV40 DNA defective in the late region. The cells appeared morphologically transformed, but did not form tumors in nude mice on repeated testing, nor were they immortalized (1). This result is consistent with the extensive clinical evidence that SV40 is not oncogenic for humans (16) and with previous reports that SV40-transformed human cells are not tumorigenic in the nude mouse assay (13) . The rare examples of SV40-transformed human cell lines that are tumorigenic probably result from further unidentified genetic changes that occurred in culture.
Prior to our studies (1, 2) , all reported experiments to examine the oncogenic properties of mutant ras genes by transfection were carried out with rodent cells. We found no foci following transfection of FS-2 cells with the mutant human HRAS (EJ) gene, either in a simple pEJ plasmid or in the pSV2gptEJ plasmid (2) . Drug-resistant clones recovered after transfection with pSV2gptEJ, though morphologically normal, contained the integrated EJ gene and expressed elevated levels of the HRAS gene product p21. These clones senesced in culture and were not tumorigenic in nude mice (1, 2) . Our results were confirmed by microinjection experiments in which mutant p21 protein was shown to have no effect on human fibroblasts; whereas in companion injections of mouse or rat cells, morphological changes were induced, and DNA synthesis was initiated (17, 18) .
In view of these negative results, we were interested in the report by Rhim et al. (12) describing immortalization of human foreskin epithelial cells following infection with an SV40-adenovirus chimeric construct, and subsequently tumorigenesis following infection with a retrovirus, Kirsten murine sarcoma virus (KiMSV), pseudotyped with baboon endogenous virus (BaEV) to facilitate entry into human cells. We report here the results of analogous experiments using human fibroblasts as recipients for KiMSV(BaEV).
Proc. Natl. Acad. Sci. USA 83 (1986) MATERIALS AND METHODS Cells. FS-2 cells were derived from a human foreskin as described (1, 2) . FSSV-27 and FSSV-46 were derived from foci induced by transfection of FS-2 cells with XSV-9, a cloned fragment in XgtWES from the SV40-transformed mouse cell line SVT2/S containing an integrated copy of SV40 DNA with a deletion in the late region (19) . Va2 is an SV40-transformed human W18 fibroblastic line selected for resistance to 8-azaguanine (13) . FSK, FSVK-27, FSVK-46, and Va2K are cell populations recovered from infection of FS-2, FSSV-27, FSSV-46, and Va2, respectively, with KiMSV(BaEV) as described below.
Culture Conditions. Cells were grown at 370C in humidified air containing 6.5% C02/93.5% air in the a modification of Eagle's minimal essential medium (MEM) with 2 g of glucose per liter/insulin at 10 ,g/ml/10% (vol/vol) fetal bovine serum (HyClone, Logan, UT)/1% human serum (GIBCO)/ penicillin, streptomycin, and glutamine as described (20) . To test for anchorage independence, plastic dishes were coated with 0.6% agar bases, and cells were added in suspension in 1.3% (wt/vol) methyl cellulose (Fisher Scientific, Medford, MA). Colonies containing more than 50 cells were counted.
Infection with KiMSV. Culture supernates containing KiMSV(BaEV) were obtained from J. Rhim and titered by him at approximately 1 x 104 focus-forming units/ml or higher. Cells were plated at 2 x 105 cells per 60-mm Petri dish for 24 hr, then the medium was removed and replaced with approximately 2.5 x 103 focus-forming units in a total of 500 ,ul of medium containing a final polybrene concentration of 4 ,g/ml. After a 2-hr incubation in a moist chamber at 37°C with occasional shaking, 3.5 ml of fresh medium was added, and cells were incubated 24 hr, then washed, released from the culture dish with trypsin, replated for further growth, and then stored in liquid N2.
Tumor Formation. Growing cells (5-10 x 106 cells) were injected subcutaneously into the flank of BALB/c nude mice as described (20) . Cell masses reaching 1 cm in diameter were scored as positive. Tumors exceeding this size that subsequently regressed are so indicated in Table 1 . To demonstrate the human cell content of excised tumors, tissue sections were pretreated with normal goat serum to reduce background, then absorbed 1 hr with rabbit anti-human P32-microglobulin (Boehringer Mannheim), rinsed, and exposed to fluorescein-conjugated goat anti-rabbit IgG. As controls, sections were treated as above except (0) Colcemid at 0.05 ,tg/ml (GIBCO) for 1-2 hr. The methods for chromosome preparations, as well as the G-banding technique employed, were essentially as described (23) . From each of the strains investigated, 25-50 cells were analyzed. The nomenclature follows the recommendations of the International System for Human Cytogenetic Nomenclature (24) .
RESULTS
Origin and Properties of SV40-Transformed FS-2 Cells. FSSV clones arose as foci following transfection of FS-2 cells with phage XSV-9 containing SV40 DNA, defective in the late region but retaining the intact origin, early regulatory region, and T-antigen coding sequences. Cells from foci were typically transformed in morphology and expressed T-antigen. FSSV-27 cells are shorter and plumper than FS-2s, grow in the disoriented manner depicted in the photograph and contain T-antigen (Fig. 1) .
Growth properties of the FSSV-27 cells compared with FS-2 and the Va2 line are shown in Table 1 . The Va2 and FSSV-27 cells formed large colonies in medium with 1% serum at, a frequency close to that in high serum. In methyl cellulose, the Va2s and FSSV-27s grew somewhat better than FS-2s and formed tight colonies at low plating efficiency. Presence of Viral p21 Protein (Fig. 2) . The expression of the RAS gene product, p21, was detected with the rat monoclonal antibody Y13-259, which binds to the HRAS and KRAS p2ls, both viral and cellular (22) Table 2 . A detailed description of the banding patterns will be reported elsewhere. The FS-2 cells were diploid, whereas after retrovirus treatment, both diploid and aneuploid FSK cells were present, consistent with the morphological evidence of a partially infected population. No characteristic markers were detected in the FSK aneuploid cells.
FSSV-27 cells were essentially hypotetraploid with a modal range of 80-90 chromosomes. The FSVK-27 cells, which formed transient tumors, had a narrow mode of 86-88 chromosomes but a wider overall range than the FSSV-27s. The FSSV-46 population contained both diploid and aneuploid cells. By subcloning, the T-antigen-positive cells were found to be aneuploid, and the T-antigen-negative cells were diploid. After retroviral treatment, as expected from the results with FS-2s, the frequency of diploids greatly decreased.
The FSVK-46s were very heterogeneous, and it was impossible to discern a modal number or any consistent markers. Despite the presence of extensive structural rearrangements including dicentrics, ring chromosomes, and fragments, the FSVK-46s did not form tumors. Both FSSV-27 and -46 contained dicentric chromosomes in about 50% of the aneuploid cells (Fig. 3) , as well as other types of markers. The characteristic appearance of dicentrics after SV40-viral infection has been reported (25) .
The Va2 cells were aneuploid with a modal number of 60-65 chromosomes. The only major difference detected between the Va2 and Va2K cells was that a large submetacentric marker found in Va2 had increased in frequency and was present in over 50% of the Va2K cells. Both the Va2 and Va2K cells contained dicentrics and ring chromosomes. FSVK-27-and Va2K-derived tumors were excised, sectioned, and tested for the presence of human cells by immunofluorescence using p2-microglobulin to detect human antigens as well as mouse antiserum to detect mouse cells. All tumors examined were composed largely of human cells.
Neither FSSV-46 nor FSVK-46 formed tumors. However, FSSV-46 was subcloned and shown to contain T-antigennegative as well as -positive cells. When the subclones were separately treated with KiMSV(BaEV), they senesced before they could be tested in nude mice. The uncloned population of FSVK-46 cells also senesced without forming tumors.
Senescence (Table 3) . To study senescence, cell populations were split 1:4 at each passage or 1:2 as cells reached confluence. Senescent cells remained attached to the plastic but stopped dividing.
FSSV cells selected as foci (2) The effect of the SV40-encoded T-antigen is clearly different in human cells from rodent cells. In experiments using the SV40 large T gene in a defective retroviral expression vector, it was shown that in primary rat cells expressing elevated levels of the large T-antigen, neither morphological changes nor tumorigenicity had been induced (27) although the transfected cell populations behaved as established cell lines (28) . In contrast, the SV40-transformed human fibroblasts produced in our laboratory were morphologically transformed but not immortalized.
Similarly, the ras genes have been shown to transform rodent cells much more effectively than human cells both in transfection studies (1, 2, 29) and by microinjection (17, 18 In conclusion, we have shown that normal human fibroblasts are resistant to tumorigenesis induced by effective infection with KiMSV and that prior transformation of these cells with SV40 DNA (defective in the late region) makes the cells susceptible to transient tumor forming ability induced by KiMSV infection. We propose that senescence or resistance to immortalization plays a key role in the protection against human cancer at the cellular level. Identification of human genes involved in senescence could provide an important set of gene products (31, 32) for use in cancer protection and therapy.
